Vimarsana
Biggest News Aggregation in the World

Hannah Deresiewicz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hannah Deresiewicz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hannah Deresiewicz Today - Breaking & Trending Today

NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highlighting Obicetrapib's ... | Region - Vimarsana News

NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highlighting Obicetrapib's ... | Region

-- Presentations include new data from OCEAN, ROSE, and ROSE2 Phase 2 clinical trials, demonstrating obicetrapib’s impact on key lipid and lipoprotein biomarkers --

NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer - Vimarsana News

NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer

NAARDEN, the Netherlands and MIAMI, April 01, 2024 -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk...

NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress - Vimarsana News

NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress

NAARDEN, the Netherlands and MIAMI, March 25, 2024 -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk...

Prime Medicine to Participate in Upcoming Investor Conferences - Vimarsana News

Prime Medicine to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 28, 2024 -- Prime Medicine, Inc. , a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that...

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Vimarsana News

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new c...